Praxis Precision Medicines (PRAX) Free Cash Flow (2019 - 2026)
Praxis Precision Medicines' quarterly Free Cash Flow came in at -$86.2 million in Q1 2026, down 62.32% year-on-year from -$228.7 million in Q1 2025, and down 12.88% quarter-over-quarter from -$76.3 million in Q4 2025.
Praxis Precision Medicines has reported Free Cash Flow for 8 years, with the latest figure at -$86.2 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 62.32% year-over-year to -$86.2 million; the trailing twelve-month figure through Mar 2026 stood at -$282.2 million (down 72.1% YoY), and the FY2025 full-year result was -$249.1 million, down 89.08% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$86.2 million, down from -$76.3 million in the prior quarter.
- The five-year high for Free Cash Flow was -$20.9 million in Q1 2024, with the low at -$86.2 million in Q1 2026.
- Average Free Cash Flow over 5 years is -$44.9 million, with a median of -$44.5 million recorded in 2022.
- Year-over-year, Free Cash Flow jumped 47.74% in 2023 and tumbled 154.47% in 2025.
- Tracing PRAX's Free Cash Flow over 5 years: stood at -$29.2 million in 2022, then climbed by 18.42% to -$23.9 million in 2023, then slumped by 135.2% to -$56.1 million in 2024, then plunged by 36.0% to -$76.3 million in 2025, then decreased by 12.88% to -$86.2 million in 2026.
- The last three Free Cash Flow figures came in at -$86.2 million (Q1 2026), -$76.3 million (Q4 2025), and -$65.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Praxis Precision Medicines | 10.11 Bn | 9.32 Bn | - | -86.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.15 Mn |
| Mar 31, 2026 | -86.15 Mn |
| Dec 31, 2025 | -76.33 Mn |
| Dec 31, 2025 | -76.33 Mn |
| Sep 30, 2025 | -65.06 Mn |
| Sep 30, 2025 | -65.06 Mn |
| Jun 30, 2025 | -54.67 Mn |
| Jun 30, 2025 | -54.67 Mn |
| Mar 31, 2025 | -53.07 Mn |
| Mar 31, 2025 | -53.07 Mn |
| Dec 31, 2024 | -56.12 Mn |
| Dec 31, 2024 | -56.12 Mn |
| Sep 30, 2024 | -27.50 Mn |
| Sep 30, 2024 | -27.50 Mn |
| Jun 30, 2024 | -27.28 Mn |
| Jun 30, 2024 | -27.28 Mn |
| Mar 31, 2024 | -20.86 Mn |
| Mar 31, 2024 | -20.86 Mn |
| Dec 31, 2023 | -23.86 Mn |
| Dec 31, 2023 | -23.86 Mn |
| Sep 30, 2023 | -23.27 Mn |
| Sep 30, 2023 | -23.27 Mn |
| Jun 30, 2023 | -31.21 Mn |
| Jun 30, 2023 | -31.21 Mn |
| Mar 31, 2023 | -32.85 Mn |
| Mar 31, 2023 | -32.85 Mn |
| Dec 31, 2022 | -29.25 Mn |
| Dec 31, 2022 | -29.25 Mn |
| Sep 30, 2022 | -44.52 Mn |
| Sep 30, 2022 | -44.52 Mn |
| Jun 30, 2022 | -57.32 Mn |
| Jun 30, 2022 | -57.32 Mn |
| Mar 31, 2022 | -54.40 Mn |
| Mar 31, 2022 | -54.40 Mn |
| Dec 31, 2021 | -45.39 Mn |
| Dec 31, 2021 | -45.39 Mn |
| Sep 30, 2021 | -24.40 Mn |
| Sep 30, 2021 | -24.40 Mn |
| Jun 30, 2021 | -30.09 Mn |
| Jun 30, 2021 | -30.09 Mn |
| Mar 31, 2021 | -25.73 Mn |
| Mar 31, 2021 | -25.73 Mn |
| Dec 31, 2020 | -20.23 Mn |
| Dec 31, 2020 | -20.23 Mn |
| Sep 30, 2020 | -13.88 Mn |
| Sep 30, 2020 | -13.88 Mn |
| Jun 30, 2020 | -9.94 Mn |
| Jun 30, 2020 | -9.94 Mn |
| Mar 31, 2020 | -8.57 Mn |
| Mar 31, 2020 | -8.57 Mn |
| Dec 31, 2019 | -9.85 Mn |
| Dec 31, 2019 | -9.85 Mn |